Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Serina Therapeutics (SER) Interest Income - Total (2024 - 2025)

Serina Therapeutics (SER) has disclosed Interest Income - Total for 2 consecutive years, with $68000.0 as the latest value for Q2 2025.

  • Quarterly Interest Income - Total rose 21.43% to $68000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $258000.0 through Jun 2025, changed N/A year-over-year, with the annual reading at $235000.0 for FY2024, 16.96% down from the prior year.
  • Interest Income - Total hit $68000.0 in Q2 2025 for Serina Therapeutics, up from $47000.0 in the prior quarter.
  • In the past five years, Interest Income - Total ranged from a high of $87000.0 in Q1 2024 to a low of $47000.0 in Q1 2025.